Product Information
GALANTAMINE HBR 8 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4433 per EA under NDC 57237005060. Its NADAC has been published 638 times since Apr 9, 2014.
Strength
8 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237005060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090957On Market Since
3/29/2011
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 8 MG TABLET has been published 638 times since Apr 9, 2014, and over the history we have for it it has declined 67.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4433 per EA |
|---|---|
| All-time high | $1.4470 (Jan 14, 2015) |
| All-time low | $0.3390 (Jan 22, 2025) |
| 52-week high | $0.5117 |
| 52-week low | $0.3701 |
| Median price | $0.5842 |
| Average price | $0.7420 |
| Largest weekly change | +57.2% (Jun 20, 2018) |
| Weeks tracked | 638 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 8 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.4433 per EA (NDC 57237005060), effective Jun 24, 2026.
How has the price of GALANTAMINE HBR 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 8 MG TABLET has declined 67.9%. It has been tracked across 638 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 8 MG TABLET?
Since Apr 9, 2014, the NADAC for GALANTAMINE HBR 8 MG TABLET has ranged from a low of $0.3390 (Jan 22, 2025) to a high of $1.4470 (Jan 14, 2015), with a median of $0.5842 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 8 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GALANTAMINE HBR 8 MG TABLET, but none are currently priced below it.
Who manufactures GALANTAMINE HBR 8 MG TABLET?
GALANTAMINE HBR 8 MG TABLET (NDC 57237005060) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification